XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Hippo Stockholders' Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non controlling Interests
Beginning balance (in shares) at Dec. 31, 2022     23,201,434        
Beginning balance at Dec. 31, 2022 $ 593.5 $ 589.9 $ 0.0 $ 1,558.0 $ (7.0) $ (961.1) $ 3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (68.1) (69.8)       (69.8) 1.7
Other comprehensive income (loss) 1.7 1.7     1.7    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     134,824        
Issuance of common stock from stock plans and contingently issuable shares 0.4 0.4   0.4      
Repurchase of common stock (in shares)     (15,472)        
Repurchase of common stock (0.2) (0.2)   (0.2)      
Shares withheld related to net share settlement (0.9) (0.9)   (0.9)      
Stock-based compensation expense 17.4 17.4   17.4      
Other (0.8) (0.2)       (0.2) (0.6)
Ending balance (in shares) at Mar. 31, 2023     23,320,786        
Ending balance at Mar. 31, 2023 543.0 538.3 $ 0.0 1,574.7 (5.3) (1,031.1) 4.7
Beginning balance (in shares) at Dec. 31, 2022     23,201,434        
Beginning balance at Dec. 31, 2022 593.5 589.9 $ 0.0 1,558.0 (7.0) (961.1) 3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (173.4)            
Ending balance (in shares) at Jun. 30, 2023     23,611,308        
Ending balance at Jun. 30, 2023 447.0 445.6 $ 0.0 1,590.9 (6.4) (1,138.9) 1.4
Beginning balance (in shares) at Mar. 31, 2023     23,320,786        
Beginning balance at Mar. 31, 2023 543.0 538.3 $ 0.0 1,574.7 (5.3) (1,031.1) 4.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (105.2) (107.8)       (107.8) 2.6
Other comprehensive income (loss) (1.1) (1.1)     (1.1)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     375,844        
Issuance of common stock from stock plans and contingently issuable shares 1.8 1.8   1.8      
Repurchase of common stock (in shares)     (85,322)        
Repurchase of common stock (1.6) (1.6)   (1.6)      
Shares withheld related to net share settlement (2.0) (2.0)   (2.0)      
Stock-based compensation expense 18.0 18.0   18.0      
Other (5.9)           (5.9)
Ending balance (in shares) at Jun. 30, 2023     23,611,308        
Ending balance at Jun. 30, 2023 $ 447.0 445.6 $ 0.0 1,590.9 (6.4) (1,138.9) 1.4
Beginning balance (in shares) at Dec. 31, 2023 24,148,308   24,148,308        
Beginning balance at Dec. 31, 2023 $ 384.7 377.9 $ 0.0 1,615.2 (2.9) (1,234.4) 6.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (33.1) (35.7)       (35.7) 2.6
Other comprehensive income (loss) (0.5) (0.5)     (0.5)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     261,416        
Issuance of common stock from stock plans and contingently issuable shares 1.2 1.2   1.2      
Shares withheld related to net share settlement (1.2) (1.2)   (1.2)      
Stock-based compensation expense 9.5 9.5   9.5      
Other (5.8)           (5.8)
Ending balance (in shares) at Mar. 31, 2024     24,409,724        
Ending balance at Mar. 31, 2024 $ 354.8 351.2 $ 0.0 1,624.7 (3.4) (1,270.1) 3.6
Beginning balance (in shares) at Dec. 31, 2023 24,148,308   24,148,308        
Beginning balance at Dec. 31, 2023 $ 384.7 377.9 $ 0.0 1,615.2 (2.9) (1,234.4) 6.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (70.3)            
Issuance of common stock from stock plans and contingently issuable shares (in shares) 100,502            
Repurchase of common stock (in shares) 0            
Ending balance (in shares) at Jun. 30, 2024 24,891,528   24,891,528        
Ending balance at Jun. 30, 2024 $ 326.6 322.6 $ 0.0 1,636.8 (3.6) (1,310.6) 4.0
Beginning balance (in shares) at Mar. 31, 2024     24,409,724        
Beginning balance at Mar. 31, 2024 354.8 351.2 $ 0.0 1,624.7 (3.4) (1,270.1) 3.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (37.2) (40.5)       (40.5) 3.3
Other comprehensive income (loss) (0.2) (0.2)     (0.2)    
Issuance of common stock from stock plans and contingently issuable shares (in shares)     481,804        
Issuance of common stock from stock plans and contingently issuable shares 1.4 1.4   1.4      
Shares withheld related to net share settlement (2.6) (2.6)   (2.6)      
Stock-based compensation expense 13.3 13.3   13.3      
Other $ (2.9)           (2.9)
Ending balance (in shares) at Jun. 30, 2024 24,891,528   24,891,528        
Ending balance at Jun. 30, 2024 $ 326.6 $ 322.6 $ 0.0 $ 1,636.8 $ (3.6) $ (1,310.6) $ 4.0